Birlasoft Ltd Q2 FY27 Earnings Call — Analysis (NSE: BSOFT)
Birlasoft reported steady Q2FY27 revenue growth of 2.1% QoQ in constant currency with resilient 15.2% EBITDA margins despite absorbing 170bps of wage hike headwinds, while reiterating confidence that H2 financial performance will surpass H1.
Result quality: watch — Margin pressure. Management sentiment: optimistic.
The take
Q2FY27 Revenue ₹1,416.2 Cr ( +2.7% QoQ ) . Guidance raised . New story: AI-led deal wins and capability building .
Results
Revenue reached ₹1,416.2 Cr (+2.7% QoQ in INR, +2.1% in CC/USD); EBITDA margin stood at 15.2% absorbing a 170bps wage increase; PAT was ₹159.6 Cr.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue | ₹1,416.2 Cr | +2.7% | qoq · Q2FY27 · in INR terms (+2.1% in USD/CC) |
| EBITDA | ₹215.3 Cr | none · Q2FY27 · $22.5 million | |
| EBITDA Margin | 15.2% | none · Q2FY27 · absorbed ~170 bps wage hike | |
| PAT | ₹159.6 Cr | none · Q2FY27 · $16.7 million; ETR 29% | |
| Deal Signings TCV | $116.1 million | +9% | yoy · Q2FY27 |
| H1 Deal Signings TCV | $285 million | +15% | yoy · Q2FY27 · H1FY27 cumulative |
| DSO | 51 days | point_in_time · Q2FY27 · as of Sep-26; 2-year best | |
| Cash & Cash Equivalents | $300.4 million | point_in_time · Q2FY27 · as of Sep-26 |
Guidance
Management expects H2FY27 financial performance to be better than H1FY27, with Q4 anticipated to be the strongest quarter, supported by deal renewals and sales force ramp-up.
What management committed to
- H2 FY27 financial performance will be better than H1 FY27 financial performance. — H2FY27
- Q4 FY27 will be the strongest quarter of the fiscal year in terms of sequential revenue growth. — Q4FY27
- The E&U vertical will absolutely turn around and return to growth over the next 2-3 quarters from Q2 FY27. — Q4FY27-Q1FY28
- Manufacturing vertical will continue to deliver revenue growth in the second half of FY27. — H2FY27
- The ongoing investments in the sales organization and domain capabilities will begin contributing to improved deal signings within a couple of quarters, making FY28 look better than FY27. — FY28
Key themes
Sequential growth recovery and AI-led deal expansion
How the narrative shifted
- AI-led deal wins and capability building: New partner credentials (AWS AI Competency, OpenAI Select) and rising AI code generation (now 33%) are positioned as concrete market proof-points driving multi-year wins across logistics, manufacturing, and healthcare.
- Sales team expansion and domain rebalancing: Management reports the hiring build-out is 90% complete, with new leaders onboarded and working toward productivity. Focus is now shifting from hiring to execution and pipeline conversion.
- Cautious revenue momentum after stagnation: Management dropped the prior refusal to give numeric forecasts and now provides specific quarter-level confidence on H2 outperformance, marking a significant shift from defensive to proactive narrative.
- Margin stability with wage offset: The 15.2% EBITDA margin delivered in Q2 is touted as proof of concept that productivity and revenue mix can offset wage costs; the 15% level is restated as the steady-state run-rate.
- Vertical divergence and recovery path: The manufacturing recovery is now treated as achieved, while the E&U turnaround timeline has been stretched from 'a quarter or two' to '2-3 quarters', softening the original optimistic framing.
- AI-driven pricing pressure and TCV-revenue gap: Previously framed as an industry-wide pricing drag creating a booking-to-revenue gap, the story is now that AI-driven internal efficiencies neutralise the pressure, allowing margins to hold.
- Capital allocation overhang: Management continues to defer to the Board with 'no new news', insisting the priority remains organic growth investment before any capital deployment decision.
- Offshore shift and quality-of-revenue improvement: This is a newly elevated theme; in prior calls offshore mix was a footnote but is now presented as a strategic lever explaining margin resilience and TCV-to-revenue conversion improvements.
Operational commentary
- Life Sciences and ERP service lines logged second consecutive quarter of sequential growth; Manufacturing grew 5.2% QoQ and BFSI grew 3.6% QoQ.
- E&U vertical remained soft due to a specific ramp-down at a European client; no further downside expected, but turnaround projected over next 2-3 quarters.
- Achieved AWS AI Services Competency status and became an OpenAI Select Partner to scale GenAI and Agentic AI offerings.
- Proprietary platforms Cogito, Lynx, and Sigma expanded AI delivery; ~33% of code is now generated via Agentic AI tools (up from ~25% a few months ago).
- Exit from non-profitable and tail accounts is fully completed; company is now back in growth and capability investment mode.
- Offshore delivery intensity continues to rise, especially for advanced AI engagements, supporting operating margins.
Analyst Q&A
Q. What explains the confidence in H2 being better than H1 given historical Q4 dips in FY25/26?
Past Q4 dips were driven by client-specific negative surprises; based on current client visibility, no such dips are anticipated, and Q4 should be the strongest quarter if deal execution continues.
Q. Why did deal TCV signings appear soft in Q2, and what is the outlook for net-new deals?
Management admitted Q2 order intake was below internal expectations as certain deals slipped into Q3/Q4 rather than being lost; new sales leadership hires take 1-2 quarters to become productive.
Q. What drove the sequential increase in other expenses?
Driven by adding ~50 resources in complementary workforce on short notice for niche skill client requirements, which yielded corresponding revenue upticks.
Q. What are the capital allocation plans for the $300.4M cash pile?
The Board is seized of the matter and management will provide updates once decided; current priority is reinvesting into business capabilities and sales.
Research and educational content only. Not investment advice.